Anthony Spitale
Pharmacist · Kentwood, LA
Anthony Spitale is a pharmacist with a practice address in Kentwood, Louisiana, and NPI 1386915718, issued on Jan 17, 2012. Check the license (Louisiana 017881, as entered in NPPES) with the Louisiana board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Anthony Spitale
- Primary taxonomy
- Pharmacist 183500000X
- License number
- 017881 LA
Self-reported in NPPES; status is on the state search - Practice location
- 72247 Fedele LN, Kentwood, LA 70444
- Phone
- (225) 270-4847
- Enumerated
- Jan 17, 2012
- Record last updated
- Jan 17, 2012 (not updated in 14 years: call before relying on the address or phone)
- Entity
- Type 1 · individual
Verify Anthony Spitale in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich Louisiana board licenses this profession
Search for license 017881Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Most of these Medicare Part D claims are vaccines, 100% of the cost of the top drugs
34 Medicare Part D claims for 31 beneficiaries, against an average of 119 among the 28,524 providers of this specialty who prescribed in Part D. Brand-name drugs were 100% of claims.
Most prescribed
Pharmacies often give vaccines under a standing order that names one clinician, and CMS counts every such claim under that clinician's NPI. These claims are therefore not a measure of this clinician's own prescribing.
- Abrysvo17 claims
- Shingrix13 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
7 pharmacist records list a practice address in Kentwood
They are 7 of the 33 NPPES records with a practice address in Kentwood, and 4,623 pharmacist records in Louisiana.
All 7 in Kentwood → All 4,623 in Louisiana → Every provider in Kentwood →
Other pharmacist records in Louisiana
- Martina Abd El Sayed, RPHWestwego, LA1174108708
- Fadi AbdallahBaton Rouge, LA1528886546
- Mahmoud Abdallah-HijazLuling, LA1376207522
- Hisham AbdelazizMandeville, LA1124700125
- Yasser AbdelazizPineville, LA1801307467
- Rana AbdelfattahNew Orleans, LA1821465436
- Rola Abdelmuhsen, PHARMDBaton Rouge, LA1184930224
- Ahmad AbdelsalamPineville, LA1114699766
- Ibrahim Abdelwahab, PHARM.DGretna, LA1013785427
- Kaleb AbebeNatchitoches, LA1386095180
Common questions
What is Anthony Spitale's NPI number?
Anthony Spitale's National Provider Identifier (NPI) is 1386915718, issued on Jan 17, 2012. An NPI identifies a provider in billing; it is not a license.
Where is Anthony Spitale located?
The NPPES record lists a practice address at 72247 Fedele LN, Kentwood, LA, 70444. Phone: (225) 270-4847. Providers update this record themselves, so call before visiting.
How can I verify Anthony Spitale's license?
NPPES lists Louisiana license number 017881, as entered by the provider. Search the Louisiana board that licenses this profession; the NPPES record confirms identity only.
How much does Anthony Spitale prescribe under Medicare Part D?
In 2024, Anthony Spitale had 34 Medicare Part D claims for 31 beneficiaries; the average among pharmacist prescribers was 119. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.